MAPT and Schnyder corneal dystrophy: These are the two main aims of the present study, which uses participant‐level data from nine cohorts included in the SCD‐plus Amyloid & Tau working group within the SCD Professional Interest Area (Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment ‐ ISTAART).